14-Jul-2026
No headlines found.
USANA Schedules Second Quarter 2026 Earnings Release and Conference Call
Business Wire (Tue, 14-Jul 4:15 PM ET)
Kevin Guest: World Cup Determination Shows the Power of Grit, Preparation, Persistence
PRNewswire (Wed, 1-Jul 7:02 AM ET)
USANA Celebrates 10 Years of Making the World a Better Place During World Service Week
PRNewswire (Tue, 16-Jun 7:22 AM ET)
USANA's Celavive Contouring Face & Neck Crme Named Among Canada's Top Skincare Products
PRNewswire (Mon, 8-Jun 6:46 AM ET)
USANA Earns Dual Best of State Honors for Product Innovation and Development
PRNewswire (Thu, 4-Jun 6:47 AM ET)
Kevin Guest Encourages Professionals to Prioritize Wellness During Professional Wellness Month
PRNewswire (Mon, 1-Jun 7:18 AM ET)
USANA Health Sciences Reports First Quarter 2026 Results
Business Wire (Tue, 5-May 4:15 PM ET)
One Capsule, Endless Glow--Radiant Skin Starts Within
PRNewswire (Mon, 27-Apr 7:07 AM ET)
USANA Schedules First Quarter 2026 Earnings Release and Conference Call
Business Wire (Wed, 15-Apr 7:00 AM ET)
Usana Health Sciences Inc develops and manufactures high-quality nutritional supplements, functional foods, and personal care products that are sold throughout the world. The company has developed and manufactured high-quality, science-based nutritional, personal care, and skincare products with a primary focus on promoting long-term health and wellness. The Company's reporting units for goodwill purposes are tied to its reportable segments: Core nutritional and Hiya direct-to-consumer. The core nutritional segment consists of three individual reporting units that are determined based on the operational nature of the business: Buy-Sell, China, and India. Geographically, it is in Asia Pacific, the Americas, and Europe. With the majority of revenue from Asia Pacific(Greater China).
Usana Health Sciences trades on the NYSE stock market under the symbol USNA.
As of July 14, 2026, USNA stock price declined to $21.40 with 44,906 million shares trading.
USNA has a beta of 1.63, meaning it tends to be more sensitive to market movements. USNA has a correlation of 0.17 to the broad based SPY ETF.
USNA has a market cap of $394.98 million. This is considered a Small Cap stock.
Last quarter Usana Health Sciences reported $250 million in Revenue and $.61 earnings per share. This beat revenue expectation by $9 million and exceeded earnings estimates by $.17.
In the last 3 years, USNA traded as high as $69.60 and as low as $16.60.
The top ETF exchange traded funds that USNA belongs to (by Net Assets): IWM, VTI, AVUV, FNDA, VDC.
USNA has underperformed the market in the last year with a return of -35.1%, while SPY returned +21.8%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in USNA shares. However, USNA has outperformed the market in the last 3 month and 2 week periods, returning +17.8% and +1.9%, while SPY returned +9.9% and +1.5%, respectively. This indicates USNA has been having a stronger performance recently.
USNA support price is $21.31 and resistance is $22.75 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that USNA shares will trade within this expected range on the day.